NYSE - Emergent BioSolutions Inc.

График котировок Emergent BioSolutions Inc.

Добавить в список сравнения Добавить в список сравнения
Добавить в список отслеживания Добавить в список отслеживания
Добавить в портфель Добавить в портфель

Основные параметры

P/E 18.02
P/S 3.5
P/BV 3.75
EBITDA 0.6045
Цена ао 102.2



Название Значение Оценка
P/S 3.5 2
P/BV 3.75 2
P/E 18.02 6
EV/EBITDA 8.96 8


Название Значение Оценка
ROA, % 11.86 4
ROE, % 24.07 7


Название Значение Оценка
Div yield, % 0
DSI 0 0


Название Значение Оценка

Импульс роста

Название Значение Оценка
Рост прибыли, % 73.01 10
Рост цены акции, % 78.61 10
Рост дивидендов, % 0 0


Название Год По итогам периода Дата закрытия реестра Дивиденды, % Дивиденды
Дивиденды 2016 II кв. 2016 01.08.2016 1.49 1.84

Основные владельцы

Institutions Объем Доля, %
BlackRock Fund Advisors 8429383 2.08
AllianceBernstein L.P. 10188705 2.51
BlackRock Asset Management Deutschland AG - ETF 2940447 0.73
Lyxor Funds Solutions S.A. 82529 0.02
Raiffeisen Kapitalanlage GmbH 500307 0.12
DWS Investment S.A. (ETF) 693055 0.17
HSBC Global Asset Management (France) 1973055 0.49
3 Banken-Generali Investment GmbH 668179 0.16
Lyxor International Asset Management S.A.S. 1080962 0.27
Amundi Asset Management 1374911 0.34
UBS Asset Management 11256804 2.78
Sparkasse Oberösterreich Kag MBH 135000 0.03
Invesco Asset Management Ltd 2804507 0.69
Erste Asset Management GmbH 54953 0.01
Caixabank Asset Management SGIIC 916885 0.23
Security Kapitalanlage AG 70411 0.02
East Capital Asset Management S.A. 222300 0.05
JP Morgan Asset Management (UK) Ltd 2155223 0.53
UBS Asset Management (Americas) Inc 864182 0.21
Pioneer Investments Austria GmbH 490776 0.12
T. Rowe Price Associates, Inc. 18676831 4.61
Schroders Investment Mgt North America 4137179 1.02
Fidelity Management & Research Company LLC 17942121 4.42

Содержится в ETF

ETF Доля, % Доходность за год, %
ALPS Medical Breakthroughs ETF 3.17 46.02
ETFMG Treatments Testing and Advancements ETF 3.59
iShares MSCI Austria ETF 16.02 18.06

Похожие компании

Описание Emergent BioSolutions Inc.

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs). The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute\u002Femergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Vaxchora, a cholera vaccine; and Vivotif, a typhoid vaccine. The company also provides NARCAN for the emergency treatment of known or suspected opioid overdose; Reactive Skin Decontamination Lotion Kit, a medical device to remove or neutralize chemical warfare agents from the skin; and Trobigard a combination drug-device auto injector product candidate. In addition, it offers raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to treat inhalational anthrax; Botulism Antitoxin Heptavalent for treating botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccination; CHIKUNGUNYA, a chikungunya virus-like particle vaccine; and ADENOVIRUS 4\u002F7. Further, the company offers other discovery and preclinical product candidates addressing PHTs, including viral hemorrhagic fevers caused by Ebola, Marburg, Sudan, and Lassa viruses; diarrheal disease caused by Shigella; and heat-labile toxin producing enterotoxigenic Escherichia coli, etc. Additionally, it offers FLU-IGIV to treat Influenza A infection; and ZIKV-IG, a prophylaxis for Zika infections, as well as contract development and manufacturing services to pharma and biotech industries, and government agencies\u002Fnon-governmental organizations. The company has collaboration agreements with Novavax Inc.; and Johnson & Johnson. Emergent BioSolutions Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.